IL-33 and ST2 levels in chronic kidney disease: Associations with inflammation, vascular abnormalities, cardiovascular events, and survival. by Ozkan Gungor, Hilmi Umut Unal, Aydin Guclu, Mustafa Gezer, Tayfun Eyileten, Fatma Betül Guzel, Orcun Altunoren, Ertugrul Erken, Yusuf Oguz, Ismail Kocyigit, Mahmut Ilker Yilmaz

Get full text

Visceral adiposity index and triglyceride/high-density lipoprotein cholesterol ratio in hypogonadism by Cem Haymana, Alper Sonmez, Aydogan Aydogdu, Serkan Tapan, Yalcin Basaran, Coskun Meric, Kamil Baskoy, Mustafa Dinc, Mahmut Yazici, Abdullah Taslipinar, Cem Barcin, Mahmut Ilker Yilmaz, Erol Bolu, Omer Azal

Get full text

Anti-Inflammatory, Antioxidant, and Anti-Atherosclerotic Effects of Natural Supplements on Patients with FMF-Related AA Amyloidosis: A Non-Randomized 24-Week Open-Label Interventio... by Micol Romano, Facundo Garcia-Bournissen, David Piskin, Ulkumen Rodoplu, Lizzy Piskin, Abdelbaset A. Elzagallaai, Tunc Tuncer, Siren Sezer, Didar Ucuncuoglu, Tevfik Honca, Dimitri Poddighe, Izzet Yavuz, Peter Stenvinkel, Mahmut Ilker Yilmaz, Erkan Demirkaya

Get full text

The Prevalence of Fabry Disease in Patients with Chronic Kidney Disease in Turkey: The TURKFAB Study by Kultigin Turkmen, Aydın Guclu, Garip Sahin, Ismail Kocyigit, Levent Demirtas, Fatih Mehmet Erdur, Erkan Sengül, Oktay Ozkan, Habib Emre, Faruk Turgut, Hilmi Unal, Murat Karaman, Cengiz Acıkel, Hasan Esen, Ebru Balli, Gulfidan Bıtırgen, Halil Zeki Tonbul, Mahmut Ilker Yılmaz, Alberto Ortiz

Get full text